Recently added

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity

He, Bo; Wood, Kira Hope; Li, Zhi-jie; Ermer, Judith Anna; Li, Ji; Bastow, Edward; Oliveira, Mafalda (EMBO Press, 2025-05)

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

Bergmann, Lothar; ALBIGES, Laurence; Ahrens, Marit; Gross-Goupil, Marine; Boleti, Ekaterini; Gravis, Gwenaelle; Suárez, Cristina (Elsevier, 2025-07)

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Tix, Tobias; Alhomoud, Mohammad; Shouval, Roni; IACOBONI, GLORIA; Cliff, Edward; Hansen, Doris (Elsevier, 2025-07-02)

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma

Dummer, Reinhard; Miller, Wilson H.; Taylor, Matthew; Heinzerling, Lucie; Sandhu, Shahneen; Butler, Marcus; MUÑOZ COUSELO, EVA (American Association for Cancer Research, 2025-01-01)

Revisiting Alma Ata: A Blueprint for Cancer Care

Benitez Fuentes, Javier David; Lastra del Prado, Rodrigo; Borregón, Miguel; De Luna, Alicia ; Lázaro Sánchez, Antonio David; Ferrández Arias, Asia; Iranzo, Patricia (SAGE Publications, 2025-09)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma

Revisiting Alma Ata: A Blueprint for Cancer Care

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity ﻿

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial ﻿

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma ﻿

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma ﻿

Revisiting Alma Ata: A Blueprint for Cancer Care ﻿

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma

Revisiting Alma Ata: A Blueprint for Cancer Care